164 related articles for article (PubMed ID: 37469759)
41. Development of an endoplasmic reticulum stress-related signature with potential implications in prognosis and immunotherapy in head and neck squamous cell carcinoma.
Fan X; Yang X; Guo N; Gao X; Zhao Y
Diagn Pathol; 2023 Apr; 18(1):51. PubMed ID: 37087456
[TBL] [Abstract][Full Text] [Related]
42. Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma.
Lin W; Xu Y; Gao J; Zhang H; Sun Y; Qiu X; Huang Q; Kong L; Lu JJ
Front Immunol; 2021; 12():757047. PubMed ID: 34675936
[TBL] [Abstract][Full Text] [Related]
43. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
44.
Yang Z; Yan G; Zheng L; Gu W; Liu F; Chen W; Cui X; Wang Y; Yang Y; Chen X; Fu Y; Xu X
Oncoimmunology; 2021 Jun; 10(1):1938890. PubMed ID: 34221701
[TBL] [Abstract][Full Text] [Related]
45. High expression of CLEC10A in head and neck squamous cell carcinoma indicates favorable prognosis and high-level immune infiltration status.
Zou M; Wu H; Zhou M; Xiao F; Abudushalamu G; Yao Y; Zhao F; Gao W; Yan X; Fan X; Wu G
Cell Immunol; 2022 Feb; 372():104472. PubMed ID: 35093731
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
[TBL] [Abstract][Full Text] [Related]
47. Molecular subtyping and prognostic risk characterization of head and neck squamous cell carcinoma based on lysosome-related genes.
Zhang A; Jin Y; Zou X; Zhang S
Medicine (Baltimore); 2023 Jul; 102(28):e34275. PubMed ID: 37443469
[TBL] [Abstract][Full Text] [Related]
48. Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma.
Hong X; Li Y; Lv Q; An J; Liu Y; Wang X; Li R; Hu Y; Liu B
Int J Immunopathol Pharmacol; 2023; 37():3946320231172075. PubMed ID: 37073715
[TBL] [Abstract][Full Text] [Related]
49. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
[TBL] [Abstract][Full Text] [Related]
50. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
Li Z; Shen L; Li Y; Shen L; Li N
Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
[TBL] [Abstract][Full Text] [Related]
51. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
52. Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma.
Xu Z; Zhang M; Guo Z; Chen L; Yang X; Li X; Liang Q; Tang Y; Liu J
Apoptosis; 2023 Jun; 28(5-6):860-880. PubMed ID: 36997733
[TBL] [Abstract][Full Text] [Related]
53. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
54. Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
Yang ZM; Liao B; Yang SS; Su T; Zhang J; Wang WM
Front Endocrinol (Lausanne); 2022; 13():943686. PubMed ID: 35898455
[TBL] [Abstract][Full Text] [Related]
55. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
56. A neural-related gene risk score for head and neck squamous cell carcinoma.
Tao ZY; Yang WF; Zhu WY; Wang LL; Li KY; Guan XY; Su YX
Oral Dis; 2024 Mar; 30(2):477-491. PubMed ID: 36346196
[TBL] [Abstract][Full Text] [Related]
57. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
58. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma.
Jin Y; Qin X
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707
[TBL] [Abstract][Full Text] [Related]
59. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract][Full Text] [Related]
60. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma.
Lu T; Chen Y; Gong X; Guo Q; Lin C; Luo Q; Tu Z; Pan J; Li J
Cancer Med; 2021 Nov; 10(21):7847-7862. PubMed ID: 34590792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]